Literature DB >> 15184978

Early vitamin E supplementation attenuates diabetes-associated vascular dysfunction and the rise in protein kinase C-beta in mesenteric artery and ameliorates wall stiffness in femoral artery of Wistar rats.

S J Wigg1, M Tare, J Forbes, M E Cooper, M C Thomas, H A Coleman, H C Parkington, R C O'Brien.   

Abstract

AIMS/HYPOTHESIS: The impact of early vitamin E supplementation on vascular function in diabetes remains unresolved. Therefore, we examined the effects of vitamin E on functional and structural parameters and on chemical markers that are disturbed in diabetes in mesenteric and femoral arteries.
METHODS: Segments of both arteries, taken from control and 8-week-old streptozotocin diabetic Wistar rats that were treated or not with vitamin E, were mounted on wire and pressure myographs, after which endothelium-dependent and -independent vasodilation was assessed. Passive mechanical wall properties and the localisation and levels of protein kinase C (PKC)-beta(2) and AGE were evaluated in these vessels.
RESULTS: Vitamin E supplementation was associated with improved endothelium-dependent and -independent vasodilatation in mesenteric arteries from diabetic rats. Impaired endothelium-dependent vasodilatation in diabetic mesenteric vessels was associated with PKC-beta(2) up-regulation and this was prevented by vitamin E supplementation. Increased AGE accumulation and plasma isoprostane levels in diabetic rats were not changed by vitamin E. In the femoral artery, vitamin E supplementation had no effect on endothelium-dependent or -independent vasodilatation, but did prevent the wall stiffening associated with diabetes. CONCLUSIONS/
INTERPRETATION: Early vitamin E supplementation has a beneficial effect on diabetes-induced endothelial dysfunction in resistance arteries. This benefit may arise from a direct effect on smooth muscle function, as a result of inhibition of the PKC-beta(2) isoform by vitamin E.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15184978     DOI: 10.1007/s00125-004-1411-x

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  37 in total

1.  Oral treatment with an antioxidant (raxofelast) reduces oxidative stress and improves endothelial function in men with type II diabetes.

Authors:  P J Chowienczyk; S E Brett; N K Gopaul; D Meeking; M Marchetti; D L Russell-Jones; E E Anggård; J M Ritter
Journal:  Diabetologia       Date:  2000-08       Impact factor: 10.122

2.  Low-density lipoproteins inhibit endothelium-dependent relaxation in rabbit aorta.

Authors:  H E Andrews; K R Bruckdorfer; R C Dunn; M Jacobs
Journal:  Nature       Date:  1987 May 21-27       Impact factor: 49.962

3.  Antioxidant effects of vitamins C and E are associated with altered activation of vascular NADPH oxidase and superoxide dismutase in stroke-prone SHR.

Authors:  X Chen; R M Touyz; J B Park; E L Schiffrin
Journal:  Hypertension       Date:  2001-09       Impact factor: 10.190

4.  Vitamin E supplementation improves endothelial function in type I diabetes mellitus: a randomized, placebo-controlled study.

Authors:  R A Skyrme-Jones; R C O'Brien; K L Berry; I T Meredith
Journal:  J Am Coll Cardiol       Date:  2000-07       Impact factor: 24.094

Review 5.  Endothelial dysfunction in diabetes.

Authors:  A S De Vriese; T J Verbeuren; J Van de Voorde; N H Lameire; P M Vanhoutte
Journal:  Br J Pharmacol       Date:  2000-07       Impact factor: 8.739

6.  Antioxidants improve impaired insulin-mediated glucose uptake and prevent migration and proliferation of cultured rabbit coronary smooth muscle cells induced by high glucose.

Authors:  K Yasunari; M Kohno; H Kano; K Yokokawa; M Minami; J Yoshikawa
Journal:  Circulation       Date:  1999-03-16       Impact factor: 29.690

7.  MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial.

Authors: 
Journal:  Lancet       Date:  2002-07-06       Impact factor: 79.321

8.  Aminoguanidine treatment increases elasticity and decreases fluid filtration of large arteries from diabetic rats.

Authors:  M S Huijberts; B H Wolffenbuttel; H A Boudier; F R Crijns; A C Kruseman; P Poitevin; B I Lévy
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

9.  Alpha-tocopherol inhibits agonist-induced monocytic cell adhesion to cultured human endothelial cells.

Authors:  R Faruqi; C de la Motte; P E DiCorleto
Journal:  J Clin Invest       Date:  1994-08       Impact factor: 14.808

10.  Low-dose alpha-tocopherol improves and high-dose alpha-tocopherol worsens endothelial vasodilator function in cholesterol-fed rabbits.

Authors:  J F Keaney; J M Gaziano; A Xu; B Frei; J Curran-Celentano; G T Shwaery; J Loscalzo; J A Vita
Journal:  J Clin Invest       Date:  1994-02       Impact factor: 14.808

View more
  11 in total

1.  Role of the PKC/CPI-17 pathway in enhanced contractile responses of mesenteric arteries from diabetic rats to alpha-adrenoceptor stimulation.

Authors:  Irem Mueed; Lili Zhang; Kathleen M MacLeod
Journal:  Br J Pharmacol       Date:  2005-12       Impact factor: 8.739

2.  Maternal alcohol consumption in pregnancy enhances arterial stiffness and alters vasodilator function that varies between vascular beds in fetal sheep.

Authors:  Helena C Parkington; Kelly R Kenna; Foula Sozo; Harold A Coleman; Alan Bocking; James F Brien; Richard Harding; David W Walker; Ruth Morley; Marianne Tare
Journal:  J Physiol       Date:  2014-04-22       Impact factor: 5.182

3.  Impact of experimental diabetes on the maternal uterine vascular remodeling during rat pregnancy.

Authors:  Julie K Phillips; Amanda M Vance; Renju S Raj; Maurizio Mandalà; Erika A Linder; Natalia I Gokina
Journal:  Reprod Sci       Date:  2012-03       Impact factor: 3.060

4.  Relaxin mediates uterine artery compliance during pregnancy and increases uterine blood flow.

Authors:  Lenka A Vodstrcil; Marianne Tare; Jacqueline Novak; Nicoleta Dragomir; Rolando J Ramirez; Mary E Wlodek; Kirk P Conrad; Laura J Parry
Journal:  FASEB J       Date:  2012-06-28       Impact factor: 5.191

5.  Expression of 14-3-3 zeta and interaction with protein kinase C in the rat retina in early diabetes.

Authors:  Y H Kim; Y S Kim; S S Kang; H S Noh; H J Kim; G J Cho; W S Choi
Journal:  Diabetologia       Date:  2005-05-21       Impact factor: 10.122

6.  Maternal melatonin administration mitigates coronary stiffness and endothelial dysfunction, and improves heart resilience to insult in growth restricted lambs.

Authors:  Marianne Tare; Helena C Parkington; Euan M Wallace; Amy E Sutherland; Rebecca Lim; Tamara Yawno; Harold A Coleman; Graham Jenkin; Suzanne L Miller
Journal:  J Physiol       Date:  2014-04-07       Impact factor: 5.182

7.  Annexin-A1 deficiency exacerbates pathological remodelling of the mesenteric vasculature in insulin-resistant, but not insulin-deficient, mice.

Authors:  Maria Jelinic; Nicola Kahlberg; Chen Huei Leo; Hooi Hooi Ng; Sarah Rosli; Minh Deo; Mandy Li; Siobhan Finlayson; Jesse Walsh; Laura J Parry; Rebecca H Ritchie; Cheng Xue Qin
Journal:  Br J Pharmacol       Date:  2020-02-11       Impact factor: 8.739

8.  Uteroplacental insufficiency programs regional vascular dysfunction and alters arterial stiffness in female offspring.

Authors:  Marc Q Mazzuca; Mary E Wlodek; Nicoleta M Dragomir; Helena C Parkington; Marianne Tare
Journal:  J Physiol       Date:  2010-04-19       Impact factor: 5.182

9.  Intrauterine growth restriction delays cardiomyocyte maturation and alters coronary artery function in the fetal sheep.

Authors:  Kristen J Bubb; Megan L Cock; M Jane Black; Miodrag Dodic; Wee-Ming Boon; Helena C Parkington; Richard Harding; Marianne Tare
Journal:  J Physiol       Date:  2006-11-23       Impact factor: 5.182

10.  Mesenteric resistance arteries in type 2 diabetic db/db mice undergo outward remodeling.

Authors:  Flavia M Souza-Smith; Paige S Katz; Aaron J Trask; James A Stewart; Kevin C Lord; Kurt J Varner; Dalton V Vassallo; Pamela A Lucchesi
Journal:  PLoS One       Date:  2011-08-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.